ABSTRACT
The first use of electronic signatures in a GMP environment came with the release in 1997 of the FDA regulation for electronic records and signatures, 21 CFR 11.* This regulation allowed for the first time the use of fully electronic work, provided the other requirements of Part 11 were met to ensure
the trustworthiness and integrity of the electronic records generated by the computerized systems.
